|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000006125 |
Summary for AP2B1 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000006125 | Gene symbol | AP2B1 |
| Gene name | adaptor related protein complex 2 subunit beta 1 | |
| HGNC | 563 | |
| Entrez ID | 163 | |
| Gene type | protein_coding | |
| Synonyms | AP2B1| | |
| UniProtAcc | P63010 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for AP2B1 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| AP2B1 | 8.37e+03 | 1.18e+00 | 2.13e-01 | 5.51e+00 | 3.51e-08 | 3.54e-07 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for AP2B1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for AP2B1 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| HNSC | cg22228613 | chr17:35577266 | CGI:chr17:35578483-35578707 | promoter | 8.67e-01 | 7.37e-01 | 2.69e+00 | 7.10e-03 | 1.57e-02 | 1.30e-01 |
Top |
Exon skipping events with PSI in TCGA for AP2B1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| HNSC | exon_skip_150985 | 3.67e-01 | 4.92e-01 | -4.29e+00 | 1.80e-05 | 1.67e-04 | -1.25e-01 |
| ESCA | exon_skip_150985 | 3.53e-01 | 4.58e-01 | -2.71e+00 | 6.80e-03 | 2.07e-02 | -1.05e-01 |
| CHOL | exon_skip_150985 | 3.38e-01 | 5.04e-01 | -2.65e+00 | 8.12e-03 | 1.96e-02 | -1.66e-01 |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| BRCA | exon_skip_150985 | 3.26e-01 | 4.42e-01 | -1.24e+01 | 1.82e-35 | 1.73e-33 | -1.16e-01 |
| BLCA | exon_skip_150985 | 3.20e-01 | 4.36e-01 | -2.73e+00 | 6.37e-03 | 2.56e-02 | -1.17e-01 |
| READ | exon_skip_150985 | 2.90e-01 | 4.19e-01 | -3.62e+00 | 3.00e-04 | 4.67e-03 | -1.29e-01 |
Top |
RNA A-to-I editing events in TCGA for AP2B1 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for AP2B1 |
TFs related to AP2B1.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | HOXB7 | AP2B1 | 4.23e+00 | 9.80e-01 | 3.47e+00 | 1.18e-02 | Male-biased |
| ACC | UNCX | AP2B1 | 4.37e+00 | 9.83e-01 | 3.57e+00 | 1.03e-02 | Male-biased |
| PAAD | ALX1 | AP2B1 | 4.52e+00 | 9.90e-01 | 3.48e+00 | 3.43e-03 | Male-biased |
| PAAD | ARGFX | AP2B1 | 4.87e+00 | 9.94e-01 | 3.73e+00 | 2.13e-03 | Male-biased |
| PAAD | BARX1 | AP2B1 | 4.46e+00 | 9.85e-01 | 3.58e+00 | 7.86e-03 | Male-biased |
| PAAD | CDC5L | AP2B1 | 5.00e+00 | 9.91e-01 | 4.04e+00 | 5.44e-03 | Male-biased |
| PAAD | DRGX | AP2B1 | 4.79e+00 | 9.91e-01 | 3.79e+00 | 4.33e-03 | Male-biased |
| PAAD | FOXA2 | AP2B1 | 4.39e+00 | 9.90e-01 | 3.24e+00 | 1.94e-03 | Male-biased |
| PAAD | FOXD3 | AP2B1 | 4.19e+00 | 9.88e-01 | 2.96e+00 | 1.29e-03 | Male-biased |
| PAAD | FOXP1 | AP2B1 | 4.52e+00 | 9.87e-01 | 3.60e+00 | 6.40e-03 | Male-biased |
| PAAD | FOXR2 | AP2B1 | 4.13e+00 | 9.87e-01 | 2.80e+00 | 7.54e-04 | Male-biased |
| PAAD | GSX1 | AP2B1 | 4.86e+00 | 9.80e-01 | 4.12e+00 | 1.60e-02 | Male-biased |
| PAAD | HOXB7 | AP2B1 | 4.42e+00 | 9.83e-01 | 3.56e+00 | 8.83e-03 | Male-biased |
| PAAD | IRF9 | AP2B1 | 4.32e+00 | 9.89e-01 | 3.19e+00 | 2.15e-03 | Male-biased |
| PAAD | IRX2 | AP2B1 | 4.75e+00 | 9.83e-01 | 3.96e+00 | 1.23e-02 | Male-biased |
| PAAD | IRX3 | AP2B1 | 4.87e+00 | 9.83e-01 | 4.09e+00 | 1.31e-02 | Male-biased |
| PAAD | ISX | AP2B1 | 4.72e+00 | 9.91e-01 | 3.72e+00 | 4.31e-03 | Male-biased |
| PAAD | LHX3 | AP2B1 | 4.34e+00 | 9.88e-01 | 3.31e+00 | 3.66e-03 | Male-biased |
| PAAD | LMX1B | AP2B1 | 4.24e+00 | 9.85e-01 | 3.27e+00 | 4.92e-03 | Male-biased |
| PAAD | MEF2D | AP2B1 | 4.14e+00 | 9.82e-01 | 3.20e+00 | 5.54e-03 | Male-biased |
| PAAD | MEIS1 | AP2B1 | 4.67e+00 | 9.87e-01 | 3.79e+00 | 7.84e-03 | Male-biased |
| PAAD | MIXL1 | AP2B1 | 5.02e+00 | 9.90e-01 | 4.12e+00 | 7.31e-03 | Male-biased |
| PAAD | PBX2 | AP2B1 | 4.35e+00 | 9.85e-01 | 3.43e+00 | 6.56e-03 | Male-biased |
| PAAD | PHOX2A | AP2B1 | 4.84e+00 | 9.91e-01 | 3.86e+00 | 4.92e-03 | Male-biased |
| PAAD | PHOX2B | AP2B1 | 4.50e+00 | 9.89e-01 | 3.50e+00 | 4.33e-03 | Male-biased |
| PAAD | PROP1 | AP2B1 | 5.03e+00 | 9.90e-01 | 4.13e+00 | 7.12e-03 | Male-biased |
| PAAD | PRRX1 | AP2B1 | 4.70e+00 | 9.87e-01 | 3.82e+00 | 7.62e-03 | Male-biased |
| PAAD | SKOR1 | AP2B1 | 4.66e+00 | 9.89e-01 | 3.71e+00 | 5.73e-03 | Male-biased |
| PAAD | SKOR2 | AP2B1 | 4.71e+00 | 9.86e-01 | 3.85e+00 | 9.05e-03 | Male-biased |
| PAAD | SOX10 | AP2B1 | 4.37e+00 | 9.88e-01 | 3.32e+00 | 3.25e-03 | Male-biased |
| PAAD | SOX13 | AP2B1 | 4.13e+00 | 9.83e-01 | 3.16e+00 | 4.88e-03 | Male-biased |
| PAAD | SOX17 | AP2B1 | 4.24e+00 | 9.86e-01 | 3.20e+00 | 3.31e-03 | Male-biased |
| PAAD | SOX2 | AP2B1 | 4.48e+00 | 9.87e-01 | 3.56e+00 | 6.18e-03 | Male-biased |
| PAAD | SOX7 | AP2B1 | 4.31e+00 | 9.86e-01 | 3.33e+00 | 4.55e-03 | Male-biased |
| PAAD | SOX9 | AP2B1 | 4.41e+00 | 9.90e-01 | 3.30e+00 | 2.44e-03 | Male-biased |
| PAAD | SPI1 | AP2B1 | 3.91e+00 | 9.83e-01 | 2.53e+00 | 5.60e-04 | Male-biased |
| PAAD | SRY | AP2B1 | 4.61e+00 | 9.90e-01 | 3.59e+00 | 3.88e-03 | Male-biased |
| PAAD | STAT5B | AP2B1 | 4.13e+00 | 9.83e-01 | 3.17e+00 | 5.25e-03 | Male-biased |
| PAAD | UNCX | AP2B1 | 4.61e+00 | 9.91e-01 | 3.56e+00 | 3.44e-03 | Male-biased |
| PAAD | YY1 | AP2B1 | 4.15e+00 | 9.82e-01 | 3.22e+00 | 5.92e-03 | Male-biased |
| PAAD | ZKSCAN2 | AP2B1 | 4.14e+00 | 9.85e-01 | 3.08e+00 | 3.00e-03 | Male-biased |
| PAAD | ZNF25 | AP2B1 | 3.97e+00 | 9.82e-01 | 2.89e+00 | 2.69e-03 | Male-biased |
| PAAD | ZNF250 | AP2B1 | 4.13e+00 | 9.84e-01 | 3.13e+00 | 4.23e-03 | Male-biased |
| PAAD | ZNF33B | AP2B1 | 4.16e+00 | 9.87e-01 | 2.96e+00 | 1.42e-03 | Male-biased |
| PAAD | ZNF35 | AP2B1 | 4.13e+00 | 9.85e-01 | 3.06e+00 | 2.93e-03 | Male-biased |
| PAAD | ZNF354B | AP2B1 | 4.27e+00 | 9.86e-01 | 3.28e+00 | 4.49e-03 | Male-biased |
| PAAD | ZNF418 | AP2B1 | 4.05e+00 | 9.84e-01 | 2.96e+00 | 2.54e-03 | Male-biased |
AP2B1 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for AP2B1 |
RBPs related to ES in AP2B1.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| UVM | ANKHD1 | exon_skip_150976 | 1.37e+01 | 2.21e-04 | 1.44e+01 | 1.00e+00 | Female-biased |
| UVM | CPEB2 | exon_skip_150970 | 8.57e+00 | 9.91e-01 | 8.16e+00 | 2.53e-03 | Male-biased |
| UVM | CPEB4 | exon_skip_150970 | 8.59e+00 | 9.91e-01 | 8.18e+00 | 2.54e-03 | Male-biased |
| THYM | ANKHD1 | exon_skip_150976 | 1.49e+01 | 1.28e-04 | 1.56e+01 | 1.00e+00 | Female-biased |
| LUSC | SAMD4A | exon_skip_150981 | 8.14e+00 | 4.96e-03 | 8.56e+00 | 9.89e-01 | Female-biased |
| COAD | SAMD4A | exon_skip_150981 | 8.71e+00 | 9.86e-01 | 8.35e+00 | 8.04e-03 | Male-biased |
| DLBC | SAMD4A | exon_skip_150981 | 8.51e+00 | 9.88e-01 | 8.12e+00 | 5.48e-03 | Male-biased |
| CHOL | ANKHD1 | exon_skip_150976 | 1.58e+01 | 9.97e-01 | 1.52e+01 | 3.07e-03 | Male-biased |
| KIRP | ANKHD1 | exon_skip_150976 | 1.45e+01 | 9.20e-04 | 1.51e+01 | 9.99e-01 | Female-biased |
| KIRP | SAMD4A | exon_skip_150981 | 8.61e+00 | 9.92e-01 | 8.14e+00 | 2.16e-03 | Male-biased |
| BRCA | ANKHD1 | exon_skip_150976 | 1.49e+01 | 9.81e-01 | 1.44e+01 | 1.94e-02 | Male-biased |
| ESCA | ANKHD1 | exon_skip_150976 | 1.40e+01 | 2.14e-03 | 1.46e+01 | 9.98e-01 | Female-biased |
| ESCA | CPEB2 | exon_skip_150970 | 7.57e+00 | 8.30e-03 | 8.04e+00 | 9.84e-01 | Female-biased |
| ESCA | CPEB4 | exon_skip_150970 | 7.59e+00 | 8.20e-03 | 8.05e+00 | 9.84e-01 | Female-biased |
| READ | ANKHD1 | exon_skip_150976 | 1.43e+01 | 6.00e-04 | 1.49e+01 | 9.99e-01 | Female-biased |
| READ | SAMD4A | exon_skip_150981 | 8.32e+00 | 9.89e-01 | 7.89e+00 | 3.50e-03 | Male-biased |
| PCPG | CPEB2 | exon_skip_150970 | 8.31e+00 | 9.88e-01 | 7.93e+00 | 5.05e-03 | Male-biased |
| PCPG | CPEB4 | exon_skip_150970 | 8.33e+00 | 9.88e-01 | 7.95e+00 | 5.03e-03 | Male-biased |
| LGG | ANKHD1 | exon_skip_150976 | 1.40e+01 | 1.19e-03 | 1.45e+01 | 9.99e-01 | Female-biased |
| GBM | ANKHD1 | exon_skip_150976 | 1.41e+01 | 6.83e-04 | 1.47e+01 | 9.99e-01 | Female-biased |
| KICH | CPEB2 | exon_skip_150970 | 8.20e+00 | 9.83e-01 | 7.86e+00 | 8.79e-03 | Male-biased |
| KICH | CPEB4 | exon_skip_150970 | 8.21e+00 | 9.84e-01 | 7.88e+00 | 8.72e-03 | Male-biased |
| KICH | SAMD4A | exon_skip_150981 | 8.53e+00 | 9.89e-01 | 8.13e+00 | 4.35e-03 | Male-biased |
| SKCM | SAMD4A | exon_skip_150981 | 8.63e+00 | 9.90e-01 | 8.20e+00 | 4.49e-03 | Male-biased |
| SARC | SAMD4A | exon_skip_150981 | 7.99e+00 | 5.74e-04 | 8.70e+00 | 9.94e-01 | Female-biased |
AP2B1 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs9909659 | chr17:42321817:G:A | - | -0.0562377971766675 | 0.0476083964180298 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs770520 | chr17:31653440:T:G | - | -0.0405013131537625 | 0.0487754088396812 | LUAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of AP2B1 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000006125 | AP2B1 | C0086132 | Depressive Symptoms | 1 | PSYGENET |